informaworld logo
HOME . ABOUT US . CONTACT US 		HELP . PUBLISH WITH US . LIBRARIANS 
ebooks logo journals logo reference works logo abstract databases logo
bullet  SIGN IN Register | Why Register? | Got a Voucher? alerts   marked lists   shopping cart 
Advert: Informa Healthcare - http://www.informahealthcare.com

informaworld

HOME   |   SEARCH   |   BROWSE
    Issues List       Latest Issue       Forthcoming Articles       Volume 50 Issue 5       Aims & Scope       Editorial Board       Instructions for Authors       Subscribe      
<< earliestearliest   < prevprev   Issue listissues   next >next   latest >>latest
Publisher Logo Publication Cover
Search within this journal

Leukemia and Lymphoma, Volume 50 Issue 5 2009

Leukemia and Lymphoma is moving!
2008 Impact Factor: 1.939 (© Thomson Reuters, Journal Citation Reports®, 2009)
ISSN: 1029-2403 (electronic) 1042-8194 (paper)
Publication Frequency: 12 issues per year
Viewing the Journal: Select the initial letter of your research topic from the list below, or enter your search term on the left.
Sort by: Title | Page | Author
< Previous • 1 • 2 • Next >
View new articles ahead of the print edition
select-down Click for help
Commentaries
Targeting angiogenesis: a novel, rational therapeutic approach for non-Hodgkin lymphoma
Jia Ruan; John P. Leonard
Pages 679 – 681
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Dose intense therapy for relapsed lymphoproliferative disorders: the more things change, the more they are the same
Amir A. Toor
Pages 682 – 683
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus-positive lymphomas: are we there yet?
Kimberley Jones; Maher K. Gandhi
Pages 684 – 686
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Expansion of regulatory T cells in B chronic lymphocytic leukemia: enhanced ‘brakes’ on host immunity
Varda Deutsch;  Chava Perry; Aaron Polliack
Pages 687 – 688
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Overcoming glucocorticoid resistance: a new pathway from an ancient Chinese medicine?
Nancy Krett; Shuo Ma
Pages 689 – 690
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Myeloma antioxidant status: the good, the bad and the reactive
Christine M. Stellrecht; Varsha Gandhi
Pages 691 – 693
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Reviews
Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia
Jacob P. Laubach;  Constantine S. Mitsiades;  Aldo M. Roccaro;  Irene M. Ghobrial;  Kenneth C. Anderson; Paul G. Richardson
Pages 694 – 702
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Invasive mold infections: recent advances in management approaches
Pranatharthi Chandrasekar
Pages 703 – 715
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Article: Clinical
A novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma – long-term results of a multicenter observation study
Oliver Weigert;  Eckhart Weidmann;  Rudolf Mueck;  Martin Bentz;  Christoph von Schilling;  Robert Rohrberg;  Kathleen Jentsch-Ullrich;  Wolfgang Hiddemann; Martin Dreyling
Pages 716 – 722
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Genetic polymorphism of the inhibitory IgG Fc receptor FcγRIIb is not associated with clinical outcome in patients with follicular lymphoma treated with rituximab
Wen-Kai Weng; Ronald Levy
Pages 723 – 727
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108
Alison T. Stopeck;  Joseph M. Unger;  Lisa M. Rimsza;  William T. Bellamy;  Maria Iannone;  Daniel O. Persky;  Michael Leblanc;  Richard I. Fisher; Thomas P. Miller
Pages 728 – 735
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Lack of HER-2 gene amplification in non-Hodgkin lymphoma using chromogenic in situ hybridisation test
Sergio Szvalb;  Moshe Stein;  Anthony Gershuny;  Eli Gez;  Amram Hadary; Jamal Zidan
Pages 736 – 740
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival
Thomas C. Shea;  Anne W. Beaven;  Dominic T. Moore;  Jonathan S. Serody;  Don A. Gabriel;  Nelson Chao;  Jon P. Gockerman;  Reynaldo A. Garcia; David A. Rizzieri
Pages 741 – 748
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Composite lymphoma with relapse of enteropathy-type T-cell lymphoma
Zunguo Du;  Jieqing Chen;  Xiaoyan Zhou;  Taiming Zhang;  Bobin Chen; Feng Tang
Pages 749 – 756
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma
Hyo Song Kim;  Kyung Hee Kim;  Kyoung Ha Kim;  Myung Hee Chang;  Sang Hoon Ji;  Do Hyoung Lim;  Kihyun Kim;  Seok Jin Kim;  Younghyeh Ko;  Chang-Seok Ki;  Sook Jung Jo;  Jae Won Lee; Won Seog Kim
Pages 757 – 763
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis
Pia Raanani;  Anat Gafter-Gvili;  Mical Paul;  Isaac Ben-Bassat;  Leonard Leibovici; Ofer Shpilberg
Pages 764 – 772
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
BCL6: somatic mutations and expression in early-stage chronic lymphocytic leukemia
Eloisa Jantus Lewintre;  Cristina Reinoso Martín;  Carlos García Ballesteros;  Jehzabel Pendas;  Carmen Benet Campos;  José Ramón Mayans Ferrer; Javier García-Conde
Pages 773 – 780
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma
Luciano J. Costa;  Shaji Kumar;  Angela Dispenzieri;  Suzanne E. Hayman;  Francis K. Buadi;  David Dingli;  Mark R. Litzow;  Morie A. Gertz; Martha Q. Lacy
Pages 781 – 787
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Article: Research
Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia
Margot Jak;  Rogier Mous;  Ester B. M. Remmerswaal;  René Spijker;  Annelieke Jaspers;  Adriana Yagüe;  Eric Eldering;  René A. W. Van Lier; Marinus H. J. Van Oers
Pages 788 – 801
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
select-up

Privacy Policy | Terms & Conditions | Accessibility | RSS
FAQs in: English . Français . Español . 中文（简体和繁體）
© 2009 Informa plc